Status:
UNKNOWN
Effect of Oral N-Acetyl Cysteine in Prevention of Necrotizing Enterocolitis in Preterm Neonates With Feeding Intolerance
Lead Sponsor:
Ain Shams University
Conditions:
Preterm Neonates and Feeding Intolerance
Necrotizing Enterocolitis
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
necrotizing enterocolitis is a dangerous disease that may be fatal especially in preterm neonates, the early features of the disease are symptoms of feeding intolerance and interruption of the baby's ...
Eligibility Criteria
Inclusion
- preterm neonates (less than or = 36 weeks gestational age )
- feeding intolerance
Exclusion
- active gastro-intestinal tract bleeding
- Gastro- intestinal tract surgical problem
- Congenital gastro-intestinal tract anomalies
- evidence of allergy to NAC
- use of prebiotics or probiotics
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 30 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06202911
Start Date
January 1 2023
End Date
March 30 2024
Last Update
January 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams university hospitals
Cairo, Egypt, 1234